Krupali Desai -First marketing leader for newly formed division in FDA

The Food and Drug Administrations’ Center for Device and Radiological Health named Krupali Desai as their Division Director for the Division of Digital Content and Marketing. 

As their first marketing hire, Krupali will be responsible for building a proactive and informative digital communications and marketing strategy; identifying and building out an audience strategy, developing the proper channel plan based on the existing internal and external channels (including social media and other owned properties) and crafting the messages and content relevant to telling the CDRH story to specific internal and external audiences. As a creative thinker and strategic planner, Krupali  will oversee the end-to-end planning for creative campaigns and ongoing thought leadership to fulfill the CDRH mission. 

Krupali Desai is a distinguished marketing leader with over 15 years of experience in driving growth and enhancing brand impact through innovative and comprehensive marketing strategies. With a proven track record spanning financial services, insurance, healthcare, and technology sectors, Krupali has consistently demonstrated her ability to build and lead dynamic marketing teams that achieve tangible results.

The Food and Drug Administration (FDA) is a Federal scientific regulatory agency with the legislated responsibility to protect and promote the public health of the Nation’s 245 million consumers. FDA is responsible for the health and safety of food and food additives, drugs, biological products, cosmetics, medical devices, and ionizing and non-ionizing radiation-emitting products and substances. Through its regulatory role, FDA national programs directly affect and profoundly impact multi-billion-dollar industries, in addition to protecting the public health of hundreds of millions of American consumers. 

The mission of the Center for Devices and Radiological Health (CDRH) is to protect and promote public health. CDRH assures that patients and providers have timely and continued access to safe, effective, and high-quality medical devices and safe radiation- emitting products. CDRH provides consumers, patients, their caregivers, and providers with understandable and accessible science-based information about the products we oversee. We facilitate medical device innovation by advancing regulatory science, providing industry with predictable, consistent, transparent, and efficient regulatory pathways, and assuring consumer confidence in devices marketed in the United States.